The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Less Than 95% Adherence to Nonnucleoside Reverse‐Transcriptase Inhibitor Therapy Can Lead to Viral Suppression
Abstract
For antiretroviral therapy, the 95% adherence "threshold" is based on nucloside-exposed patients who are receiving partially suppressive, unboosted protease inhibitor regimens. Using unannounced pill counts and electronic medication monitoring, viral suppression is common with a 54%-100% mean adherence level to nonnucleoside reverse-transcriptase-inhibitor regimens. Although perfect adherence is an important goal, viral suppression is possible with moderate adherence to potent regimens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection
Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M., & Singh, N. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00004 · Cited by 3,289
Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., Bamberger, J. D., Chesney, M. A., & Moss, A. (2000) · AIDS · doi:10.1097/00002030-200003100-00008 · Cited by 1,033
Self-citationStaszewski, S., Morales-Ramirez, J., Tashima, K. T., Rachlis, A., Skiest, D., Stanford, J., Stryker, R., Johnson, P., Labriola, D. F., Farina, D., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912163412501 · Cited by 993
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS
Bangsberg, D. R., Perry, S., Charlebois, E. D., Clark, R. A., Roberston, M., Zolopa, A. R., & Moss, A. (2001) · AIDS · doi:10.1097/00002030-200106150-00015 · Cited by 960
Self-citationMarzolini, C., Telenti, A., Decosterd, L. A., Greub, G., Biollaz, J., & Buclin, T. (2001) · AIDS · doi:10.1097/00002030-200101050-00011 · Cited by 840
Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Chang, C., Buono, D., Eckholdt, H., Howard, A. A., & Schoenbaum, E. E. (2001) · Clinical Infectious Diseases · doi:10.1086/323201 · Cited by 637
Impact of Adherence and Highly Active Antiretroviral Therapy on Survival in HIV-Infected Patients
de Olalla, P. G., Knobel, H., Carmona, A., Guelar, A., López-Colomés, J. L., & Caylà, J. A. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200205010-00014 · Cited by 430
Hogg, R. S., Heath, K., Bangsberg, D., Yip, B., Press, N., O'Shaughnessy, M. V., & Montaner, J. S. G. (2002) · AIDS · doi:10.1097/00002030-200205030-00012 · Cited by 425
Self-citationHarrigan, P. R., Hogg, R. S., Dong, W. W. Y., Yip, B., Wynhoven, B., Woodward, J., Brumme, C. J., Brumme, Z. L., Mo, T., Alexander, C. S., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/427192 · Cited by 424
Bangsberg, D. R., Acosta, E. P., Gupta, R., Guzman, D., Riley, E. D., Harrigan, P. R., Parkin, N., & Deeks, S. G. (2006) · AIDS · doi:10.1097/01.aids.0000199825.34241.49 · Cited by 312
Self-citation
Cited by
Gardner, E. M., McLees, M. P., Steiner, J. F., del Rio, C., & Burman, W. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq243 · Cited by 1,893
Behavioural strategies to reduce HIV transmission: how to make them work better
Coates, T. J., Richter, L., & Caceres, C. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60886-7 · Cited by 760
Thompson, M. A., Mugavero, M. J., Amico, K. R., Cargill, V. A., Chang, L. W., Gross, R., Orrell, C., Altice, F. L., Bangsberg, D. R., Bartlett, J. G., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-11-201206050-00419 · Cited by 582
Self-citationA pandemic of the poor: Social disadvantage and the U.S. HIV epidemic.
Pellowski, J. A., Kalichman, S. C., Matthews, K. A., & Adler, N. (2013) · American Psychologist · doi:10.1037/a0032694 · Cited by 469
Nachega, J. B., Hislop, M., Nguyen, H., Dowdy, D. W., Chaisson, R. E., Regensberg, L., Cotton, M., & Maartens, G. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318199072e · Cited by 449
Kim, S.-H., Gerver, S. M., Fidler, S., & Ward, H. (2014) · AIDS · doi:10.1097/qad.0000000000000316 · Cited by 431
Finitsis, D. J., Pellowski, J. A., & Johnson, B. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088166 · Cited by 355
Azar, M. M., Springer, S. A., Meyer, J. P., & Altice, F. L. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.06.014 · Cited by 394
Adherence to Nonnucleoside Reverse Transcriptase Inhibitor–Based HIV Therapy and Virologic Outcomes
Nachega, J. B., Hislop, M., Dowdy, D. W., Chaisson, R. E., Regensberg, L., & Maartens, G. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-8-200704170-00007 · Cited by 374
Sweeney, S. M., & Vanable, P. A. (2016) · AIDS and Behavior · doi:10.1007/s10461-015-1164-1 · Cited by 350
Pazos, C., Pontón, J., & Palacio, A. D. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.1.299-305.2005 · Cited by 337
Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm
Haberer, J. E., Bangsberg, D. R., Baeten, J. M., Curran, K., Koechlin, F., Amico, K. R., Anderson, P., Mugo, N., Venter, F., Goicochea, P., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000647 · Cited by 319
Self-citationAdherence to Highly Active Antiretroviral Therapy (HAART): A Meta-Analysis
Ortego, C., Huedo-Medina, T. B., Llorca, J., Sevilla, L., Santos, P., Rodríguez, E., Warren, M. R., & Vejo, J. (2011) · AIDS and Behavior · doi:10.1007/s10461-011-9942-x · Cited by 310
Ng, B., Chu, A., & Khan, M. M. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002468 · Cited by 301
Adherence to Antiretroviral Therapy and Virologic Failure: A Meta-Analysis
Bezabhe, W. M., Chalmers, L., Bereznicki, L. R., & Peterson, G. M. (2016) · Medicine · doi:10.1097/md.0000000000003361 · Cited by 277
HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts
B. Nachega, J., C. Marconi, V., U. van Zyl, G., M. Gardner, E., Preiser, W., Y. Hong, S., J. Mills, E., & Gross, R. (2011) · Infectious Disorders - Drug Targets · doi:10.2174/187152611795589663 · Cited by 271
Horberg, M. A., Silverberg, M. J., Hurley, L. B., Towner, W. J., Klein, D. B., Bersoff-Matcha, S., Weinberg, W. G., Antoniskis, D., Mogyoros, M., Dodge, W. T., et al. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318160d53e · Cited by 264
Oyugi, J. H., Byakika-Tusiime, J., Ragland, K., Laeyendecker, O., Mugerwa, R., Kityo, C., Mugyenyi, P., Quinn, T. C., & Bangsberg, D. R. (2007) · AIDS · doi:10.1097/qad.0b013e32802e6bfa · Cited by 263
Self-citationBärnighausen, T., Chaiyachati, K., Chimbindi, N., Peoples, A., Haberer, J., & Newell, M.-L. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70181-5 · Cited by 246
Preventing HIV Antiretroviral Resistance through Better Monitoring of Treatment Adherence
Bangsberg, D. R. (2008) · The Journal of Infectious Diseases · doi:10.1086/533415 · Cited by 183
Self-citationMbuagbaw, L., van der Kop, M. L., Lester, R. T., Thirumurthy, H., Pop-Eleches, C., Ye, C., Smieja, M., Dolovich, L., Mills, E. J., & Thabane, L. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003950 · Cited by 147
Dale, S., Cohen, M., Weber, K., Cruise, R., Kelso, G., & Brody, L. (2014) · AIDS Patient Care and STDs · doi:10.1089/apc.2013.0329 · Cited by 135
Chung, M. H., Richardson, B. A., Tapia, K., Benki-Nugent, S., Kiarie, J. N., Simoni, J. M., Overbaugh, J., Attwa, M., & John-Stewart, G. C. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000422 · Cited by 109
Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy
Viswanathan, S., Justice, A. C., Alexander, G. C., Brown, T. T., Gandhi, N. R., McNicholl, I. R., Rimland, D., Rodriguez-Barradas, M. C., & Jacobson, L. P. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000643 · Cited by 98
Williams, E. C., McGinnis, K. A., Edelman, E. J., Matson, T. E., Gordon, A. J., Marshall, B. D. L., Bryant, K. J., Rubinsky, A. D., Lapham, G. T., Satre, D. D., et al. (2019) · AIDS and Behavior · doi:10.1007/s10461-018-2210-6 · Cited by 97
Barai, N., Monroe, A., Lesko, C., Lau, B., Hutton, H., Yang, C., Alvanzo, A., McCaul, M. E., & Chander, G. (2017) · AIDS and Behavior · doi:10.1007/s10461-016-1580-x · Cited by 53
Mekuria, L. A., Prins, J. M., Yalew, A. W., Sprangers, M. A. G., & Nieuwkerk, P. T. (2016) · Tropical Medicine & International Health · doi:10.1111/tmi.12709 · Cited by 41
de Sumari-de Boer, I. M., van den Boogaard, J., Ngowi, K. M., Semvua, H. H., Kiwango, K. W., Aarnoutse, R. E., Nieuwkerk, P. T., & Kibiki, G. S. (2016) · AIDS and Behavior · doi:10.1007/s10461-015-1254-0 · Cited by 40
Gemeda, D. H., Gebretsadik, L. A., Dejene, T., Wolde, M., & Sudhakar, M. (2012) · JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/01938924-201210560-00001 · Cited by 6
Metadata
- Authors
- Bangsberg, D. R.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-10
- Volume
- 43
- Issue
- 7
- Pages
- 939-941
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W1973708179
- Cited by
- 534
- References
- 17
- FWCI
- 21.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.